Cargando…

Lack of efficacy of Interferon β-1a in COVID-19 patients with mild to moderate pneumonia

Detalles Bibliográficos
Autores principales:	Bosi, Carlo, Ferrarese, Roberto, De Lorenzo, Rebecca, Mancini, Nicasio, Bosi, Emanuele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Federation of Internal Medicine. Published by Elsevier B.V. 2023
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715494/ https://www.ncbi.nlm.nih.gov/pubmed/36517370 http://dx.doi.org/10.1016/j.ejim.2022.11.033

Ejemplares similares

Interferon β-1a (IFNβ-1a) in COVID-19 patients (INTERCOP): study protocol for a randomized controlled trial
por: Bosi, Emanuele, et al.
Publicado: (2020)

Blood ozonization in patients with mild to moderate COVID-19 pneumonia: a single centre experience: reply
por: De Monte, Amato, et al.
Publicado: (2021)

Comments on the article “Social desirability bias in qualitative health research”
por: Bosi, Maria Lúcia Magalhães
Publicado: (2023)

Comparison of the efficacy and tolerability of telmisartan and enalapril in patients of mild to moderate essential hypertension
por: Saha, Lekha
Publicado: (2011)

Renal thrombotic microangiopathy induced by β-interferon
por: Li Cavoli, Gioacchino, et al.
Publicado: (2011)

Supine vs prone position in mild to moderate COVID-19 pneumonia: The impact of proning on computed tomography findings
por: Piciucchi, S, et al.
Publicado: (2022)

SARS-CoV-2 infection despite high levels of vaccine-induced anti-Receptor-Binding-Domain antibodies: a study on 1110 health-care professionals from a northern Italian university hospital
por: Ferrari, Davide, et al.
Publicado: (2022)

Beneficial impact of Baricitinib in COVID-19 moderate pneumonia; multicentre study
por: Cantini, Fabrizio, et al.
Publicado: (2020)

Re: The first report on coronavirus disease 2019 vaccine refusal by patients with cancer in Italy: Early data from a single-institute survey: Consideration of recent findings on COVID-19 vaccine adherence in cancer patients
por: Cavanna, Luigi, et al.
Publicado: (2021)

Relative Bradycardia in Patients with Mild-to-Moderate Coronavirus Disease, Japan
por: Yan, Gabriel, et al.
Publicado: (2021)

The need for a correct oxygen-ozone autohemotherapy (O(3)-AHT) in patients with mild to moderate COVID-19 pneumonia
por: Chirumbolo, Salvatore, et al.
Publicado: (2021)

Five severe COVID-19 pneumonia patients treated with triple combination therapy with lopinavir/ritonavir, hydroxychloroquine, and interferon β-1b
por: Hong, Sun In, et al.
Publicado: (2020)

The role of noninvasive ventilation in mild to moderate acute respiratory distress syndrome
por: Rao, Manimala S., et al.
Publicado: (2015)

Role of methyle blue in the management of mild, moderate and severe COVID-19 disease
por: Bawaskar, Himmatrao Saluba, et al.
Publicado: (2022)

Letter regarding “The clinical efficacy of low-dose whole-lung irradiation in moderate-to-severe COVID-19 pneumonia: RTMX-20 trial”
por: Li, Zheng, et al.
Publicado: (2023)

Association of neuronal injury blood marker neurofilament light chain with mild-to-moderate COVID-19
por: Ameres, Markus, et al.
Publicado: (2020)

RSRC1 loss-of-function variants cause mild to moderate autosomal recessive intellectual disability
por: Scala, Marcello, et al.
Publicado: (2020)

Mild to moderate clinical course of COVID-19 infection in patients with common variable immune deficiency
por: Lesichkova, Spaska, et al.
Publicado: (2023)

Lack of efficacy for sotrovimab use in patients with COVID-19: A meta-analysis
por: Ao, Guangyu, et al.
Publicado: (2022)

Lack of efficacy of direct oral anticoagulants compared to warfarin in antiphospholipid antibody syndrome
por: Giarretta, Igor, et al.
Publicado: (2022)

Experience with a single dose of recombinant activated factor VII for the management of mild-to-moderate bleeds in haemophilia
por: ALMAGRO, D, et al.
Publicado: (2011)

Concomitant bilastine and montelukast as additive therapy for seasonal allergic rhinoconjunctivits and mild‐to‐moderate asthma. The SKY study
por: Lavorini, Federico, et al.
Publicado: (2019)

Lack of Efficacy of SGLT2-i in Severe Pneumonia Related to Novel Coronavirus (nCoV) Infection: No Little Help from Our Friends
por: Bossi, Antonio Carlo, et al.
Publicado: (2020)

Pneumonia Caused by Shigella sonnei in Man Returned from India
por: Mancini, Fabiola, et al.
Publicado: (2009)

Effect of tocilizumab versus standard of care in adults hospitalized with moderate-severe COVID-19 pneumonia
por: Aomar-Millán, Ismael F., et al.
Publicado: (2022)

Antibodies reacting with Simian Virus 40 capsid protein mimotopes in serum samples from patients affected by uveal melanoma
por: Bononi, Ilaria, et al.
Publicado: (2014)

Lack of reversibility for NOACs
por: Al-Kindi, Sadeer
Publicado: (2014)

Divergent humoral responses in mild to moderate SARS-CoV-2 infection over time – indication of persistence of the virus?
por: Bürgi, Justus J., et al.
Publicado: (2022)

In COVID-19 patients with mild or moderate respiratory failure, duration and type of symptoms influence the diagnostic accuracy of lung ultrasound
por: Victoria, Pawlowska, et al.
Publicado: (2022)

Re: Efficacy of favipiravir in adults with mild COVID-19 by Bosaeed et al.
por: Mori, Nobuaki
Publicado: (2022)

Mild Decrease in Blood Glucose Levels May Predict Efficacy of Antipsychotic Lurasidone
por: Nagamine, Takahiko, et al.
Publicado: (2023)

Lack of Transmission of Vaccinia Virus
por: Stark, James H., et al.
Publicado: (2006)

Response to ‘Lack of reversibility for NOACs’
por: Kaba, Riyaz A, et al.
Publicado: (2014)

Superiority of a vitamin B(12)-containing emollient compared to a standard emollient in the maintenance treatment of mild-to-moderate plaque psoriasis
por: Del Duca, Ester, et al.
Publicado: (2017)

Combined Prophylactic and Therapeutic Use Maximizes Hydroxychloroquine Anti-SARS-CoV-2 Effects in vitro
por: Clementi, Nicola, et al.
Publicado: (2020)

Dupilumab efficacy in adolescents with uncontrolled, moderate‐to‐severe asthma: LIBERTY ASTHMA QUEST
por: Maspero, Jorge F., et al.
Publicado: (2021)

Letter to the editor on “Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial” by Udwadia et al
por: Medisetty, Mahender Kumar, et al.
Publicado: (2021)

Evaluation of the efficacy and safety of hydroxychloroquine in comparison with chloroquine in moderate and severe patients with COVID-19
por: Li, Qiuyu, et al.
Publicado: (2021)

Dual-Domain Reporter Approach for Multiplex Identification of Major SARS-CoV-2 Variants of Concern in a Microarray-Based Assay
por: Damin, Francesco, et al.
Publicado: (2023)

Clinical efficacy of nitric oxide nasal spray (NONS) for the treatment of mild COVID-19 infection
por: Winchester, Stephen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_87cdt0hsuvffqu390ellsanub6